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Rationale
Plasma low-density lipoprotein cholesterol (plasma LDL-C), vascular endothelial cells and
peripheral blood mononuclear cells (PBMCs), particularly monocytes, play key roles in initiating atherosclerosis, the primary cause of cardiovascular disease (CVD). Although the
mechanisms underlying development of atherosclerosis are not well understood, LDL-C is
known to influence expression of endothelial microRNAs (miRNAs) and gene-targets of
miRNAs to promote cell senescence. However, the impact of LDL-C on expression of
PBMC miRNAs and miRNA targeted genes in response to an atherogenic diet is not known.
In this study, we used unbiased methods to identify coordinately responsive PBMC miRNAgene networks that differ between low and high LDL-C baboons when fed a high-cholesterol, high-fat (HCHF) diet.

Methods and results
Using RNA Seq, we quantified PBMC mRNAs and miRNAs from half-sib baboons discordant for LDL-C plasma concentrations (low LDL-C, n = 3; high LDL-C, n = 3) before and
after a 7-week HCHF diet challenge. For low LDL-C baboons, 626 genes exhibited significant change in expression (255 down-regulated, 371 up-regulated) in response to the
HCHF diet, and for high LDL-C baboons 379 genes exhibited significant change in expression (162 down-regulated, 217 up-regulated) in response to the HCHF diet. We identified
494 miRNAs identical to human miRNAs and 47 novel miRNAs. Fifty miRNAs were differentially expressed in low LDL-C baboons (21 up- and 29 down-regulated) and 20 in high LDLC baboons (11 up- and 9 down-regulated) in response to the HCHF diet. Among the differentially expressed miRNAs were miR-221/222 and miR-34a-3p, which were down-regulated, and miR-148a/b-5p, which was up-regulated. In addition, gene-targets of these
miRNAs, VEGFA, MAML3, SPARC, and DMGDH, were inversely expressed and are
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central hub genes in networks and signaling pathways that differ between low and high LDLC baboon HCHF diet response.
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We have identified coordinately regulated HCHF diet-responsive PBMC miRNA-gene networks that differ between baboons discordant for LDL-C concentrations. Our findings provide potential insights into molecular mechanisms underlying initiation of atherosclerosis
where LDL-C concentrations influence expression of specific miRNAs, which in turn regulate expression of genes that play roles in initiation of lesions.

Conclusions

Introduction
Cardiovascular disease (CVD), the leading cause of morbidity and mortality in developed
countries [1,2], is commonly associated with development of atherosclerosis. The pathophysiological characteristics of atherosclerosis are a consequence of interactions between genetic
and environmental factors including diet. Clinical and epidemiological studies indicate that
atherosclerotic burden is positively correlated with plasma LDL-C concentrations [3–6], and
high LDL-C concentration is a major risk factor or atherosclerosis [7].
High LDL-C concentrations contribute greatly to the initiation of atherosclerosis, whereby
LDL particles and associated cholesterol activate adhesion molecules on vascular endothelial
cells (EC), reduce synthesis of EC-derived relaxing factor, and promote EC apoptosis [7, 8]. It
is posited that upon activation of adhesion molecules, PBMCs, particularly monocytes, adhere
to the endothelium, infiltrate the neointima through the endothelial layer, phagocytize LDL-C
and transform to macrophages, triggering inflammation-signaling cascades. Previous in vitro
studies demonstrated that LDL-C, particularly oxidized LDL-C (ox-LDL-C), induces EC apoptosis by regulating the expression of genes and miRNAs. For example, ox-LDL-C induces EC
apoptosis by down-regulating BCL2 [9, 10] and the miR-222/221 family [11], while up-regulating miR-365 [12].
Previously we showed that hepatic miR-222/221 was down-regulated in response to feeding
a HCHF diet to baboons with high LDL-C concentrations [13]. In the current study, we
hypothesized that PBMC miRNAs and miRNA gene-targets are differentially expressed in
response to changes in LDL-C concentrations, and that miRNA-gene networks are concomitantly modulated. To test this hypothesis, half-sib adult baboons (Papio hamadryas) exhibiting
discordant LDL-C plasma concentrations (low and high LDL-C) were challenged for 7 weeks
with a HCHF diet. Blood samples were collected before and after the diet challenge. We quantified all PBMC-expressed genes and miRNAs by unbiased RNA Seq.
We identified differentially expressed genes and miRNAs, inversely expressed miRNA
gene-targets and their integrated networks, and gene ontologies and biological pathways modulated in response to changes in LDL-C concentrations. By analyzing half-sib baboons discordant for the LDL-C plasma concentrations (> 2 S.D. difference), we minimized genetic
variation due to genetic background and increased the likelihood that we would discover miRNAs and miRNA gene-targets that are LDL-C responsive.
The baboon is a well-characterized model for dyslipidemia and atherosclerosis [6, 14] and
is very similar to humans both physiologically and genetically [15], suggesting that findings in
baboons will translate to humans. In addition to genetic background, we are able to control
diet and environment in baboons, which is very difficult in humans. To our knowledge, the
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influence of LDL-C concentrations on PBMC miRNA and miRNA gene-target expression has
not been investigated in primates. Identification of baboon PBMC miRNAs and miRNA genetargets that are differentially expressed in response to changes in LDL-C concentrations may
provide insights into understanding mechanisms by which early atherosclerosis is initiated,
potentiating discovery of novel therapeutic targets and biomarkers for dyslipidemia.

Materials and methods
Animals
Baboons were bred and maintained at the Southwest National Primate Research Center
(SNPRC), Texas Biomedical Research Institute (Texas Biomed), which is accredited by the
Association for Assessment and Accreditation of Laboratory Animal Care International. The
animals were maintained in outdoor group housing, which provided full social environment
and physical activity, and food and drink ad libitum. The Texas Biomedical Research Institute’s Institutional Animal Care and Use Committee approved experimental protocols, and
SNPRC veterinarians and veterinary staff conducted all procedures, and all efforts were made
to minimize suffering. The animals were not euthanized after the experiments.

Selection of baboon half-sib-pairs discordant for LDL-C
Based on phenotypic and genotypic analysis of 951 pedigreed baboons, we identified three
half-sib-pairs with contrasting phenotypes for LDL-C concentrations as described. The members of each half-sib-pair differed by at least two standard deviations for LDL-C concentrations
[16].

Diet challenge
Half-sib baboons were maintained on a chow diet that is low in fat (4% of calories) and cholesterol (0.03 mg/kcal) and challenged for 7 weeks with HCHF diet, which is high in fat (40% of
calories) and cholesterol (1.7 mg/kcal). The dietary components and the dietary challenge protocols have been described [17].

Sample collection
Prior to sample collection, baboons were sedated with ketamine (10 mg/kg), given atropine
(0.025 mg/kg) and intubated. Blood pressure was measured by automated arm cuff (Collin),
and oxygen saturation, heart and respiration rates were monitored by pulse oximetry. Blood
samples (10 ml) were collected by venipuncture in EDTA tubes, before (n = 6) and after the
HCHF challenge diet (n = 6). Whole blood was centrifuged at 10,000g for 10 min, and buffy
coats were aspirated and stored at -80˚C.

RNA isolation
Total RNA was isolated and purified from buffy coats of 12 samples using TRIzol Reagent and
miRNeasy Mini Kit (Qiagen) as described previously [18]. RNA quantity was assessed spectrophotometrically using a NanoDrop 8000 (Thermo Fisher Scientific, Wilmington, DE), and
quality was assessed using an Agilent Bioanalyzer 2100 (Agilent, Santa Clara, CA). RNA integrity was assessed by electrophoresis in a denaturing 1% agarose gel and stored at −80˚C until
further use.
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RNA sequencing and data analysis
Complementary DNA (cDNA) was generated for RNA Seq using Illumina’s mRNA Seq Sample Preparation Kit according to the manufacturer’s protocol and as described previously [18].
Briefly, we enriched for mRNAs using poly-A selection and fragmented the mRNA by chemical fragmentation. We generated the first strand of cDNA using reverse transcription and Illumina’s random hexamer primers, and the second strand using DNA Polymerase I and RNase
H. We multiplexed all samples in one pool and hybridized the pool to an individual lane of a
flow cell for cluster generation using the Illumina Paired End Cluster Generation Kitv4
(2x100bp) and Cluster Station. Sequencing was performed using the Illumina v4 Sequencing
Kit and HiSeq 2500 Sequencer.
The sequencing output FASTQ files (GEO accession number: GSE114722) were analyzed
using default settings of Partek Flow (Partek Inc., MO). Briefly, paired sequence reads for each
sample were trimmed bases from the 5’ end, followed by trimming of bases from both ends for
sequence reads with a Phred score of less than 30.The sequence reads were aligned with STAR
aligner v2.3.1j to baboon transcriptome (Ensembl PapAnu2 release 76). To quantify the
expression levels of transcripts, the mapped reads were normalized using transcripts per kilobase million (TPM), whereby read counts were divided by the length of a gene in kilobase to
compute reads per kilobase (RPK). The sum of all RPK values in a sample were divided by 106
to compute ‘per million scaling factor’. Finally, each RPK was divided by the ‘per million scaling factor’ to obtain TPM. The reads were quantified using Partek’ expectation maximization
(EM) algorithm. Differential expression of genes was evaluated using Partek’s gene specific
analysis (GSA). The goal of GSA is to identify a statistical model that is the best for a specific
gene, and then to use the best model to test for differential expression.
Using GSA, p values and fold-change for each gene, calculated as normalized ratio of
mapped reads before and after diet challenge, were outputted. Finally, using Partek Genomic
Suite we generated unsupervised hierarchical clustering of profiles of differentially expressed
genes.

Functional enrichment analysis
To enhance the understanding of the biological relevance of all differentially expressed genes
before and after HCHF diet challenge in low and high LDL-C baboons, we performed functional enrichment analysis using ClueGO, a plug-in app for Cytoscape [19]. ClueGo facilitates
generation of functionally grouped gene ontology and pathway networks and charts to decipher the biological relevance of expressed genes. The statistical test used for the enrichment
was based on the both-sided hypergeometric option with a Benjamini-Hoschberg correction
and kappa score of 0.4. In addition, we invoked the GO Term Fusion option as well as biological, functional, molecular and immunity GO terms.
To further understand the biological relevance of the genes that were common and
inversely expressed in both low and high LDL baboons, we performed network analysis using
ConsensusPathDB-human (http://cpdb.molgen.mpg.de/), a web-based analysis tool. The significance of GO terms and pathways was tested with p value set at <0.01, a minimum overlap
with input genes set at 2 and a GO level 5 category option.

Small RNA sequencing and data analysis
We used protocols and procedures described previously [13] and used the same RNA samples
that were used for RNA Seq above. After isolating RNA, we enriched the sample with sncRNAs
by using mirVana miRNA Isolation Kit (Ambion). We used 2μg of sncRNAs to synthesis
cDNA. After purification, the ibraries were quantified using QuBit fluorometry and Nanodrop
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8000 spectrometry. Library clones were generated using cBot, and sequenced using Illumina’s
Genome Analyzer (GAIIx). Sequence reads analysis and identification of differentially
expressed miRNAs were done using mirTools [20]. For the miRNAs, sequence reads (SRA
accession number: SRP148696) were normalized using reads per million mapped to miRNA
(RPMM), whereby the sum of miRNA specific read counts per sample was divided by 106 to
compute ‘per million scaling factor’. Finally, read counts were divided by the ‘per million scaling factor’ to compute RPMM.

Identification of gene-miRNA integrated networks
To identify miRNA-gene integrated networks, we used MiRNA Target Filter in IPA. Briefly,
we uploaded both differentially expressed miRNAs and differentially expressed genes and
identified miRNA targets using TargetScanHuman v6.2/Tar-Base/MiRecords software embedded in IPA. TargetScanHuman considers matches to human 3’ UTRs and their orthologs. We
used the Build function to connect inversely expressed miRNA-mRNA molecules and generate
networks. The low LDL-C network was overlaid on a miRNA-gene list for high LDL baboons
to generate a high LDL-C network.

Statistical analysis
Statistical analysis was performed using algorithms embedded in miRTool for miRNA expression profiles and Partek Genomic Suite for gene expression profiles. Arithmetic means derived
from three samples for baboons fed chow or HCHF diet per baboon phenotype were used to
identify differentially expressed miRNAs and genes, and analyzed by a two-tailed paired t- test.
One sample two-tailed t-test was used to test the mean difference in LDL-C concentrations of
the animals before and after diet challenge. Statistical significant threshold was set at p < 0.05.
Where appropriate multiple testing analysis was performed to correct p values using Benjamini-Hochberg method described by McDonald JH. (2014) [21].
For the miRNA analysis, we used 5% False Discovery Rate (FDR) and 20% for the gene
analysis; meaning that we accepted the possibility that 20% of the genes with p values less than
0.05 are likely false positive. Statistically significant pathways and GO terms were determined
using algorithms embedded in IPA, ClueGo, or ConsensusPathDP-human software. P-values
<0.05 were considered statistically significant.

Results
LDL-C concentrations in low and high LDL-C baboon baboons
Table 1 illustrates changes of LDL-C concentrations after the HCHF diet challenge. For both
low and high LDL-C baboons, LDL-C concentrations increased significantly after diet challenge (low, p = 0.01; high, p = 0.03). For the high LDL-C baboons, LDL-C concentrations
increased 2-fold compared to low LDL-C baboons after the HCHF diet challenge (p = 0.02).
Table 1. Plasma LDL-CLDL-C concentrations before and after HCHF diet challenge in low and high.
LDL-C baboons
Diet

Chow

HCHF

Low LDL-C Baboons

19.3 (8.1)

31.3 (2.5)

High LDL-C Baboons

43.7 (15.0)

114.3 (19.5)

Standard deviations are indicated in parenthesis.
https://doi.org/10.1371/journal.pone.0213494.t001
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Table 2. Low LDL-C baboons: Top 35 genes that exhibit greatest change in response to HCHF diet.
Up-regulated
Gene symbol

Down-regulated

Corrected p-value

Fold-Change

Gene symbol

Corrected p-value

Fold-Change

U4

0.014

4.2

LOC101026757

0.040

-35.7

IGKV1OR2-108

0.003

3.0

LOC101017602

0.079

-33.1

ENKUR

0.011

2.9

ALB

0.041

-29.7

TMEM40

0.006

2.8

CPS1

0.034

-28.7

GEMIN7

0.001

2.7

PLG

0.069

-27.0

NRBF2

0.037

2.7

HRG

0.017

-26.6

PPIL3

0.003

2.7

FGG

0.071

-25.5

RGS16

0.056

2.7

LOC101022486

0.045

-22.4

IGKV4-1

0.018

2.6

ITIH2

0.074

-22.2

MRPL47

0.004

2.6

TTR

0.035

-20.2

LOC101019904

0.005

2.5

LOC101023648

0.022

-18.6

MEX3B

0.052

2.5

ITIH1

0.020

-18.2

BORCS5

0.004

2.4

LOC100998199

0.012

-16.3

LOC101009271

0.046

2.4

LOC101000951

0.046

-16.2

TMEM177

0.001

2.4

TAT

0.030

-16.0

CLEC9A

0.002

2.4

C9

0.076

-15.7

NRARP

0.025

2.4

HMGCS2

0.074

-15.2

NINJ1

0.015

2.4

AGT

0.053

-14.2

MRPL50

0.005

2.3

ADH4

0.047

-13.3

CCL22

0.001

2.3

SLCO1B1

0.048

-11.9

SGPP1

0.017

2.3

C2

0.021

-11.7

GPR171

0.065

2.3

C5

0.015

-11.5

ND3

0.022

2.3

PON1

0.010

-11.0

GRPEL2

0.009

2.3

LOC101017967

0.069

-10.7

CCDC102A

0.006

2.3

C6

0.020

-10.3

SLAMF9

0.008

2.3

APOC3

0.062

-10.3
-9.8

TROVE2

0.024

2.3

ARG1

0.008

ST6GALNAC3

0.048

2.3

LOC100998476

0.071

-9.4

PPA2

0.007

2.3

SLC2A2

0.066

-9.4

BCL10

0.003

2.3

SERPING1

0.064

-9.1

COPS4

0.009

2.3

LOC101001292

0.013

-8.5

LAMTOR1

0.007

2.2

AFM

0.062

-8.4

HOXB7

0.002

2.2

OTC

0.008

-8.3

MBD5

0.012

2.2

SERPINF2

0.060

-8.2

TCEAL1

0.005

2.2

LOC101002090

0.031

-7.8

https://doi.org/10.1371/journal.pone.0213494.t002

Differential expression of PBMC genes responsive to HCHF diet
We identified genes that were differentially expressed in response to LDL-C concentration
changes by analyzing the expression levels before and after HCHF diet challenge. For low
LDL-C baboons, 626 genes (255 down-regulated, 371 up-regulated) exhibited significant
change in expression, while 272 genes (114 down-regulated, 158 up-regulated) remained significantly differentially expressed in high LDL-C baboons after p-value correction (S1 Table).
Tables 2 and 3 show the top 35 genes with highest change in response to HCHF diet. Fig 1
shows unsupervised hierarchical clustering of gene expressionprofiles in low and high LDL-C
baboons.
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Table 3. High LDL-C baboons: Top 35 genes that exhibit greatest change in response to HCHF diet.
Up-regulated
Gene symbol

Down-regulated

Corrected p-value

Fold-Change

ALDOB

0.026

36.0

LRP2

0.046

SLC34A1
SLC22A2

Gene symbol

Corrected p-value

Fold-Change

HRH2

0.011

-1.8

20.9

BCL9L

0.039

-1.8

0.037

18.7

MAML3

0.033

-1.8

0.031

14.1

IKZF1

0.038

-1.8

IGFBP5

0.034

11.5

GAS7

0.037

-1.8

EPHX2

0.022

9.9

FAM129C

0.040

-1.9

AGXT2

0.032

9.6

NIPAL3

0.011

-1.9

SLC22A6

0.010

9.4

IQSEC1

0.026

-1.9

IGFBP7

0.037

9.1

EXTL3

0.037

-1.9

HSD11B2

0.038

7.7

FAM102B

0.039

-1.9

TSPAN1

0.027

6.8

CUL9

0.024

-1.9

CALB1

0.035

5.9

MGAT3

0.042

-1.9

SLC6A18

0.032

5.6

XKRX

0.004

-1.9

LGALS2

0.036

5.3

CR2

0.003

-1.9

SLC47A2

0.047

5.0

NUDCD2

0.046

-1.9

SLC3A1

0.026

4.7

LY96

0.023

-1.9

OSGIN1

0.048

4.5

KIAA1549L

0.001

-2.0

MIOX

0.034

4.5

TCHP

0.003

-2.0

SDC4

0.040

4.4

TXNL4B

0.028

-2.0

CGNL1

0.008

4.3

PLEKHA2

0.038

-2.0

COL4A2

0.045

4.3

ST6GAL1

0.044

-2.0

SLC12A3

0.024

4.3

TRIM25

0.036

-2.1

SPARC

0.009

3.4

TMED8

0.021

-2.1

KCNJ15

0.040

3.4

BACH2

0.008

-2.1

GPT

0.027

3.3

CSPG4

0.011

-2.1

HNF1B

0.042

3.3

AFF3

0.027

-2.1

NOX4

0.040

3.3

AGBL2

0.003

-2.2

DPYS

0.045

3.2

FCRL5

0.028

-2.2

ESRRG

0.036

3.1

ROBO2

0.030

-2.2

CES2

0.005

3.0

TET3

0.010

-2.2

USH1C

0.009

2.9

KIF26A

0.002

-2.3

VEGFA

0.005

2.8

ELMSAN1

0.001

-2.3

CTSL

0.011

2.7

LIPN

0.009

-2.3

SERPINH1

0.044

2.6

SWAP70

0.001

-2.5

DMGDH

0.039

2.6

NFATC2

0.001

-2.8

https://doi.org/10.1371/journal.pone.0213494.t003

Moreover, we used ClueGO (http://apps.cytoscape.org/apps/cluego), an application for
Cytoscape, to identify networks of both gene ontology (GO) and pathways influenced by genes
differentially expressedin low and high LDL-C baboons. Fig 2 shows functionally grouped networks of GO terms and pathways associated with expressed genes in low LDL-C baboons,
including VLDL particle remodeling, regulation of cholesterol transport, endothelial cell apoptotic process, and negative regulation of blood vessel morphogenesis. For high LDL-C
baboons, GO terms and pathways included coronary vasculature development, heart valve
morphogenesis, kidney epithelium development, distal tubule and collecting duct development (Fig 3).
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Genes expressed in both low and high LDL-C baboons
Eighteen differentially expressed genes were common in both low and high LDL-C baboons
(Table 4). After p-value correction, 14 genes remained significantly differentially expressed in
both groups. Among the 14 genes, 3 genes (VEGFA, SPARC and DMGDH) were inversely
expressed between the two groups. MAML3, PKD1L3 and LIN9 were inversely expressed
between the phenotypes but their differential expression was nominal in low LDL-C baboons.
Fig 4 shows a network of GO and pathways associated with the differentially expressed genes.
The top GO terms that were statistically significant included regulation of angiogenesis, regulation vascular development, regulation of hematopoietic progenitor cell differentiation, and
kidney endothelial angiogenesis.

Annotation of small RNAs and identification of novel miRNAs
The proportion of expressed sncRNAs for each type of annotated sncRNA is shown in Fig 5.
Fig 5A shows combined data for low and high LDL-C baboons. miRNAs were the most

Fig 1. Dendrogram showing unsupervised hierarchical clustering of baboon PBMC gene expression profiles in low and high LDL-C baboons in response to
HCHF diet. Columns and rows, respectively, denote genes and time points.
https://doi.org/10.1371/journal.pone.0213494.g001
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Fig 2. GO/pathway terms networks enriched for differentially expressed genes in low LDL-C baboons, respectively. Terms are represented as nodes linked
based on their kappa score 0.4, where only the label of the most significant term per group is shown. The node size represents the term enrichment significance.
The node color denotes different GO terms, and color gradient shows the gene proportion of each cluster associated with the term.
https://doi.org/10.1371/journal.pone.0213494.g002

abundantly expresse of the annotated sncRNAs (93%). Other sncRNAs, such as small interfering RNAs (siRNAs), small nucleolar RNAs (snoRNAs), small nuclear RNAs (snRNAs), and
transfer RNAs (tRNAs), comprised 4% of the total expressed sncRNAs. Repeat-associated
RNAs accounted for only 1% of the sncRNAs.
Unique sncRNAs that did not map (“unclassified”) to any sncRNA databases or to the
human genome comprised approximately 2% of the sncRNAs expressed in all baboon PBMC
libraries. Fig 5B and 5 show the data, respectively, for low LDL-C baboons and high LDL-C
baboons. A higher proportion of miRNAs were expressed in low LDL-C baboons (96%) compared with high LDL-C baboons (90%).However, the difference was not statistically significant. Other non-coding RNAs accounted for only 2% of the total expressed sncRNAs in low
LDL-C baboons and 6% for high LDL-C baboons (Fig 4B and 4C).
We identified 541 distinct miRNAs in baboon PBMCs: 494 were identical to human miRNAs, herein referred to as known miRNAs, and 47 were novel baboon miRNAs (Table 5). A
greater number of known and novel miRNAs were expressed in low LDL-C than high LDL-C
baboons. All known and novel miRNAs are shown in S2 and S3 Tables.

Differential expression of PBMC miRNAs in response to a HCHF diet
MiRNAs that were differentially expressed in response to a HCHF diet in low and high LDL-C
baboons are shown in Fig 6. Fifty miRNAs were differentially expressed in low LDL-C baboons
(21 up- and 29 down-regulated). For high LDL-C baboons, 20 miRNAs were differentially
expressed in response to LDL- C level change (11 up- and 9 down-regulated). The miR-30
family was down-regulated in both low and high LDL-C baboons. Notable miRNAs up-regulated in low LDL-C PBMCs but not significantly differentially expressed in high LDL-C
baboons included miR-33b, 29b, 16, 155 and 26b. The miR- 221/222 family was down-regulated in high LDL-C baboons but not significantly differentially expressed in low LDL-C
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Fig 3. GO/pathway terms networks enriched for differentially expressed genes in high LDL-C baboons, respectively. Terms are represented as nodes
linked based on their kappa score 0.4, where only the label of the most significant term per group is shown. The node size represents the term enrichment
significance. The node color denotes different GO terms, and color gradient shows the gene proportion of each cluster associated with the term.
https://doi.org/10.1371/journal.pone.0213494.g003

samples. Table 6 shows the miRNA nucleotide sequences, p values and fold changes of these
miRNAs.
We identified star miRNAs (complementary sequence to mature miRNA) that were differentially expressed and exhibited discordant expression in low and high LDL-C baboons. MiR34a� and 374a� (miR-34a-3p and 374a-3p) were up-regulated in low LDL-C baboons and
down-regulated in high LDL-C baboons. Interestingly, miR-148a and miR-148b were up-regulated in low LDL-C baboons while complementary sequences, miR-148a� (miR-148a-5p) and
miR-148b� (miR-148b-5p), were up-regulated in high LDL-C baboons.

Targets of differentially expressed miRNAs
We used IPA to identify miRNA gene-targets that are differentially expressed and inversely
correlated with differentially expressed miRNAs. Table 7 shows that the total number of targeted genes for low LDL- C baboons was significantly greater than for high LDL-C baboons, zscore = 24.6, p<0.001. These miRNA targets included genes involved in lipid exchange and
transport, angiogenesis and glucose homeostasis such as APOL1, VEGFA, IGFBP5, and
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Table 4. Common PBMC genes differentially expressed in low and high LDL-C baboons.
Gene ID

Low LDL-C baboons
Fold-

High LDL-C baboons

P-value

change

Corrected

Fold-

P-value

change

P-value

Corrected
P-value

VEGFA

-2.59

0.005

0.012

2.77

0.005

0.005

DMGDH

-2.63

0.024

0.043

2.64

0.037

0.039

SPARC

-2.42

0.027

0.047

3.43

0.009

0.009

MAML3

1.71

0.04

0.072

-1.83

0.031

0.033

PKD1L3

1.19

0.019

0.063

-1.19

0.035

0.036

LIN9

1.54

0.043

0.075

-1.54

0.029

0.031

GFRA2

1.33

0.002

0.004

1.21

0.031

0.033

PRMT8

1.33

0.037

0.064

1.36

0.044

0.047

SLAMF9

2.27

0.004

0.008

1.69

0.028

0.03

-1.23

0.019

0.02

-1.23

0.037

0.04

SNORD124
TMEM203

1.67

0.021

0.02

1.62

0.031

0.033

-1.71

0.021

0.02

-1.78

0.022

0.022

7SK

1.34

0.002

0.004

1.8

0.041

0.043

AK5

1.94

0.013

0.01

1.72

0.025

0.03

CLEC4E

1.61

0.044

0.041

1.79

0.006

0.006

DDN

1.62

0.005

0.012

1.51

0.044

0.047

DMRT2

1.51

0.012

0.01

1.48

0.021

0.021

FOXC1

1.59

0.034

0.031

1.54

0.025

0.03

UBN2

https://doi.org/10.1371/journal.pone.0213494.t004

MAMAL3. S4 Table shows all genes that were differentially expressed and inversely correlated
with differentially expressed miRNAs in low and high LDL-C baboons.

Expression of miRNAs and miRNA-targets is coordinated in response to
LDL-C levels
We integrated differentially expressed genes and differentially expressed miRNAs in response
to HCHF diet in low and high LDL-C baboons. Notably, the genes and miRNAs were identified from the same samples. Figs 7 and 8 show networks of miRNAs and miRNA targets that
were inversely expressed in low and in high LDL-C baboons, respectively. We found out that
VEGFA, MAML3, and LRP2 are major hubs that are differentially expressed between low and
high LDL-C baboons and inversely expressed in respect to miRNAs that are differentially
expressed in low and high LDL–C baboons.

Discussion
Plasma high LDL-C concentration is a major risk factor for atherosclerosis, the leading cause
of CVD. LDL-C contributes greatly to the development and progression of atherosclerosis by
inducing the expression of EC adhesion molecules and ameliorating endothelial cell apoptosis.
Various studies have shown that LDL-C particles, particularly when oxidized, induce EC apoptosis by altering the expression of miRNAs or miRNA target genes in vitro [11, 12]. In addition, PBMCs, particularly monocytes play a key role during initiation of atherogenesis, where
they infiltrate vascular intima and differentiate to macrophages, triggering a cascade of inflammatory signals. Further, recent studies have demonstrated that monocyte-derived exosomes
transport miRNAs that activate adhesion molecules of EC in vitro [22, 23]. Previously, we
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Fig 4. Networks of GO/pathway terms for differentially expressed genes common to low and high LDL-C baboons. Terms are represented as nodes linked
based on their kappa score 0.4, where only the label of the most significant term per group is shown. The node size represents the term enrichment significance.
The color gradient shows the proportion of the number of genes for each cluster associated with the term.
https://doi.org/10.1371/journal.pone.0213494.g004

showed that LDL-C concentrations influence the expression of hepatic miRNAs in response to
a HCHF diet [13]. In the current study, we aimed to assess differential expression of PBMC
miRNAs and miRNA gene-targets in baboons differing in LDL-C response to a HFHC diet,
together with identification of coordinately expressed miRNAs and miRNA gene-targets using
unbiased methods. To address these aims we combined high throughput RNA sequencing
together with bioinformatics, including TargetScan software embedded in IPA, EM algorithm
in Partek package, GO and KEGG pathway analysis. To our knowledge this is the first study to
interrogate the expression of miRNAs and miRNA targets in PBMCs in response to a HCHF
diet challenge in nonhuman primates discordant forLDL-C response to a dietary challenge.
We observed that 626 genes were differentially expressed in response to a HCHF diet challenge in low LDL baboons and 272 genes in high LDL baboons multiple testing correction.
The top 35 gens with highest fold change in low LDL-C baboons includes CPS, which catalyzes
synthesis of carbamoyl phosphate and mutation in the gene leads to susceptibility to persistent
hypertension, and PLG, the precursor for plasmin and angiotensin. Mutation in PLG leads to
thrombophilia. The top 35 genes in high LDL-C baboons includes ALDOB, which is a glycolytic enzyme, and a lipoprotein receptor (LRP2).
Eighteen genes were differentially expressed in response to HCHF diet in both low LDL-C
baboons and high LDL-C baboons. Among the 18 genes, 3 (VEGFA, DMGDH and SPARC)
were inversely expressed between the baboon phenotypes. These PBMC candidate genes
whose expression is influenced by dyslipidemia in baboons are potential therapeutic targets.
Future studies will validate their expressionand decipher the molecular mechanisms associated
with dyslipidemia.
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Fig 5. Proportion of sncRNAs in a) both low and high LDL-C, b) high LDL-C only and c) low LDL-C only PBMC samples. Segments in the donut
diagram represent the proportions of different categories of small RNAs. Notably, “other non-coding RNAs” include snoRNAs, tRNAs, siRNAs,and
snRNAs.
https://doi.org/10.1371/journal.pone.0213494.g005

For miRNAs, 70 were differentially expressed; 50 in low LDL-C and 20 in high LDL-C
baboons. Notable miRNAs include miR545-3, which exhibited 322-fold change in high LDL-C
baboons, miR-221\222, miR- 34a, and 148a/b. Integration of differentially expressed miRNAs,
and, inversely, differentially expressed genes targeted by these miRNAs, revealed that the
major hubs are regulated by multiple miRNAs. Forexample, in high LDL-C baboons, VEGFA
is targeted by miR-34a-5p and miR-344d-3p, and MAML3 is putatively targeted by miR-499,
miR-148a-3p, miR-423-5p, miR-101-3p and miR-411-5p. These observations are consistent
with previous knowledge that miRNAs coordinately regulate major gene hubs in a complex
network by binding at multiple sites to fine tune their expression.
Importantly, we observed differing integrated GO terms and pathways in low and high
LDL-C baboon groups. For low LDL-C baboons, the major G0 terms and pathways associated
with expressed genes in response to HCHF diet are linked to lipid metabolism. In contrast,
GO terms and pathways associated with vascular development, apoptosis and kidney development are enriched for genes expressed in high LDL-C baboons. Genes expressed in both
groups are associated with angiogenesis and vascular development. The high plasma cholesterol in high LDL-C baboons is associated with attenuated lipid metabolism pathways and
Table 5. PBMC miRNAs expressed in baboons.
Phenotype

Human orthologous miRNAs

Novel baboon miRNAs

Low LDL-C only

35

17

High LDL-C only

23

15

Common to low and high LDL-C

436

15

Total

494

47

https://doi.org/10.1371/journal.pone.0213494.t005
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Fig 6. A Venn diagram showing PBMC miRNAs differentially expressed in response to HCHF diet in low and high LDL-C baboons.
https://doi.org/10.1371/journal.pone.0213494.g006

activated epithelial development pathways, possibly in response to endothelium injury modulated by LDL-C.

Candidate genes and signaling pathways
VEGFA and VEGF signaling pathway. VEGFA is a major ligand for the VEGFR1 receptor that is involved in VEGF signaling pathway, implicated in many pathophysiological conditions, including CVD. In our study, the VEGFA was down-regulated inlow LDL-C baboons,
and up-regulated in high LDL-C baboons. Our findings indicate that the high LDL-C plasma
concentrations correlated with increased expression of VEGFA in PBMCs.
LDL-C plays a major role initiating atherosclerosis, and one possible mechanism involves
up-regulation of VEGFA. It’s plausible that PBMC-secreted VEGFA may interact with monocyte VEGFA receptor to induce atherogenesis-related inflammatory cytokines. In mice, cholesterol loaded in macrophagesinfluenced the up-regulation of VEGFA [24]. In humans, VEGFA
was up-regulated in neointimal lesions compared to control [25]. Future studies will investigate the mechanistic role of VEGFA expressed in PBMCs in response to HCHF diet, in relation
to atherogenesis, and whether VEGFA is a potential biomarker for dyslipidemia.
DMGDH and choline oxidative pathway. DMGDH encodes an enzyme that catalyzes the
demethylation of dimethylglycine (DMG), leading to the subsequent formation of sarcosine
and glycine in a canonical choline oxidative pathway in the mitochondria [26]. In our study,

PLOS ONE | https://doi.org/10.1371/journal.pone.0213494 March 15, 2019

14 / 23

LDL-cholesterol and miRNA-gene networks

Table 6. Differentially expressed PBMC miRNAs in response to HCHF diet in low and high LDL-C baboons.
miRNA-ID

p-value

Fold-change

mature miRNA sequence

miR-545-3p

0.04

322.54

UCAGCAAACAUUUAUUGUGUGC

miR-25-5p

0.01

7.28

AGGCGGAGACUUGGGCAAUUG

miR-423-5p

0.00

7.06

UGAGGGGCAGAGAGCGAGACUUU

miR-34a-3p

0.05

4.48

CAAUCAGCAAGUAUACUGCCCU

miR-148b-3p

0.00

4.20

UCAGUGCAUCACAGAACUUUGU

miR-374a-3p

0.02

4.19

CUUAUCAGAUUGUAUUGUAAUU

miR-101-3p

0.05

4.01

UACAGUACUGUGAUAACUGAA

miR-152-3p

0.04

3.93

UCAGUGCAUGACAGAACUUGG

miR-148a-3p

0.04

3.75

UCAGUGCACUACAGAACUUUGU

miR-330-3p

0.03

3.59

GCAAAGCACACGGCCUGCAGAGA

miR-194-3p

0.03

3.20

CCAGUGGGGCUGCUGUUAUCUG

miR-21-5p

0.05

2.99

UAGCUUAUCAGACUGAUGUUGA

miR-499-3p

0.03

2.67

AACAUCACAGCAAGUCUGUGCU

miR-449a

0.05

2.53

UGGCAGUGUAUUGUUAGCUGGU

miR-744-5p

0.03

2.29

UGCGGGGCUAGGGCUAACAGCA

miR-433-3p

0.00

-0.73

AUCAUGAUGGGCUCCUCGGUGU

miR-188-5p

0.04

-1.53

CAUCCCUUGCAUGGUGGAGGG

miR-222-3p

0.05

-1.61

AGCUACAUCUGGCUACUGGGU

miR-411-5p

0.01

-1.64

UAGUAGACCGUAUAGCGUACG

miR-410-3p

0.04 -1.65

AAUAUAACACAGAUGGCCUGU

miR-221-3p

0.03 -1.68

AGCUACAUUGUCUGCUGGGUUUC

High LDL-C baboons

Low LDL-C baboons
miR-144-5p

0.01

16.20

GGAUAUCAUCAUAUACUGUAAG

miR-191-3p

0.04

7.21

GCUGCGCUUGGAUUUCGUCCCC

miR-33b-5p

0.05

6.56

GUGCAUUGCUGUUGCAUUGC

miR-29a-5p

0.04

5.68

ACUGAUUUCUUUUGGUGUUCAG

miR-1294

0.00

4.58

UGUGAGGUUGGCAUUGUUGUCU

miR-192-5p

0.04

4.39

CUGACCUAUGAAUUGACAGCC

miR-148a-5p

0.01

4.28

AAAGUUCUGAGACACUCCGACU

miR-142-3p

0.05

3.53

UGUAGUGUUUCCUACUUUAUGGA

let-7g-3p

0.04

3.27

CUGUACAGGCCACUGCCUUGC

miR-132-3p

0.04

3.13

UAACAGUCUACAGCCAUGGUCG

miR-374b-5p

0.01

3.02

AUAUAAUACAACCUGCUAAGUG

miR-148b-5p

0.01

3.01

AAGUUCUGUUAUACACUCAGGC

miR-103a-3p

0.01

2.92

AGCAGCAUUGUACAGGGCUAUGA

miR-532-5p

0.01

2.85

CAUGCCUUGAGUGUAGGACCGU

miR-26b-5p

0.02

2.84

UUCAAGUAAUUCAGGAUAGGU

miR-126a-5p

0.04

2.69

CAUUAUUACUUUUGGUACGCG

miR-93-3p

0.03

2.43

ACUGCUGAGCUAGCACUUCCCG

miR-16-2-3p

0.01

2.42

CCAAUAUUACUGUGCUGCUUUA

miR-155-5p

0.04

2.31

UUAAUGCUAAUCGUGAUAGGGGU

miR-2355-5p

0.00 -1.08

AUCCCCAGAUACAAUGGACAA

miR-2114-5p

0.01 -1.10

UAGUCCCUUCCUUGAAGCGGUC

miR-34a-3p

0.04 -1.12

CAAUCAGCAAGUAUACUGCCCU

miR-3940-3p

0.02 -1.16

CAGCCCGGAUCCCAGCCCACUU

miR-3653-3p

0.01 -1.19

CUAAGAAGUUGACUGAAG
(Continued )
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Table 6. (Continued)
miRNA-ID

p-value

Fold-change

mature miRNA sequence

miR-337-5p

0.04 -1.22

GAACGGCUUCAUACAGGAGUU

miR-331-3p

0.05 -1.22

GCCCCUGGGCCUAUCCUAGAA

miR-19b-3p

0.01 -1.25

UGUGCAAAUCCAUGCAAAACUGA

miR-362-3p

0.02 -1.25

AACACACCUAUUCAAGGAUUCA

miR-1296-5p

0.04 -1.26

UUAGGGCCCUGGCUCCAUCUCC

miR-193b-3p

0.04 -1.27

AACUGGCCCUCAAAGUCCCGCU

miR-3120-5p

0.03 -1.33

CACAGCAAGUGUAGACAGGCA

miR-491-3p

0.00 -1.37

CUUAUGCAAGAUUCCCUUCUAC

miR-545-5p

0.05 -1.37

UCAGUAAAUGUUUAUUAGAUGA

miR-204-5p

0.01 -1.38

UUCCCUUUGUCAUCCUAUGCCU

miR-377-3p

0.02 -1.41

AUCACACAAAGGCAACUUUUGU

miR-23a-3p

0.04 -1.42

AUCACAUUGCCAGGGAUUUCC

miR-491-5p

0.03 -1.42

AGUGGGGAACCCUUCCAUGAGG

miR-376c-3p

0.04 -1.43

AACAUAGAGGAAAUUCCACGU

miR-136-3p

0.03 -1.44

CAUCAUCGUCUCAAAUGAGUCU

miR-15a-5p

0.02 -1.47

UAGCAGCACAUAAUGGUUUGUG

miR-379-3p

0.04 -1.49

UAUGUAACAUGGUCCACUAACU

miR-32-5p

0.05 -1.49

UAUUGCACAUUACUAAGUUGCA

miR-7-1-3p

0.01 -1.55

CAACAAAUCACAGUCUGCCAUA

miR-374a-5p

0.02 -1.57

UUAUAAUACAACCUGAUAAGUG

miR-192-3p

0.05 -1.57

CUGCCAAUUCCAUAGGUCACAG

miR-660-5p

0.01 -1.63

UACCCAUUGCAUAUCGGAGUUG

miR-197-3p

0.00 -1.63

UUCACCACCUUCUCCACCCAGC

miR-532-3p

0.01 -1.65

CCUCCCACACCCAAGGCUUGCA

miR-1247-5p

0.04 -1.70

ACCCGUCCCGUUCGUCCCCGGA

0.04 3.52

UGUAAACAUCCUCGACUGGAAG

Both low and high LDL-C baboons
miR-30-5p
https://doi.org/10.1371/journal.pone.0213494.t006

DMGDH was up-regulated in high LDL-C baboons while it was down- regulated in low
LDL-C baboons in response to HCHF diet. Our findings suggest that the concentrationof
plasma cholesterol influences the expression of DMGDH, likely in response to accumulated
DMG levels.
Aberrant plasma levels of DMG are associated with various pathophysiological conditions.
Elevated DMG plasma levels are associated with atherosclerotic CVD [27] and mortality [28],
impaired renal function [29] and CRP-related inflammation [27]. Because DMHDH catalyzes
metabolism of DMG, it is likely that increased levels of DMG will be accompanied by
increased expression of DMGDH. Our results will stimulate further studies to investigate
whether DMGDH expression is correlated with DMG plasmalevels, and their potential role in
the development of atherosclerosis.
Table 7. Number of miRNA gene-targets inversely correlated with miRNA expression in low and highLDL-C
baboons.
Phenotypes

Up-regulated

Down-regulated

Total

Low LDL-C

348

69

417

High LDL-C

9

44

53

https://doi.org/10.1371/journal.pone.0213494.t007
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Fig 7. Networks of PBMC miRNAs and miRNA targets that are inversely expressed in low baboons, respectively. Genes and miRNAs are represented as
nodes. Red nodes indicate up-regulated genes, and green nodes denote down-regulated miRNAs. The intensity of the color indicates the degree of differential
expression. Numerals below each colored node represent expression fold-change and P-values. The molecular relationship between nodes is represented as a
line (edge); arrows indicate the direction of interaction.
https://doi.org/10.1371/journal.pone.0213494.g007

SPARC and TGF/B signaling pathway. SPARC encodes an extracellular matrix glycoprotein molecule that is involved in transduction of a plethora of cell signaling pathways, including TGF-beta pathway by interacting with TGF/B receptor II [30–32]. Other pathways
regulated by SPARC include Wnt/beta-catenin and MAPK pathways [33, 34].
We found that SPARC expression was up-regulated in high LDL-C baboons and down-regulated in low LDL-C baboons. Our results corroborate with a previous study which indicated
that ox-LDL-C influenced SPARC expression [35]. The mechanisms that link high LDL-C and
SPARC expression are unclear, but it is likely high LDL-C may stimulate expression of SPARC
in PBMCs. The subsequent secretion of SPARC proteins into circulation may trigger inflammation, vascular endothelial cell apoptosis, and vascular smooth cell proliferation to initiate
atherosclerosis.
In other studies, elevated plasma concentrations of SPARC are associated with diabetes
mellitus, inflammation and dyslipidemia [36] and obesity [37]—all risk factors for cardiovascular disease. These results correlate with findings that SPARC plasma concentrations are
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Fig 8. Networks of PBMC miRNAs and miRNA targets that are inversely expressed in high LDL-C baboons, respectively. Genes and miRNAs are
represented as nodes. Rednodes indicate up-regulated genes, and green nodes denote down-regulated miRNAs. The intensity of the color indicates the degree
of differential expression. Numerals below each colored node represent expression fold-change and P-values. The molecular relationship between nodes is
represented as a line (edge); arrows indicate the direction of interaction.
https://doi.org/10.1371/journal.pone.0213494.g008

elevated in patients with coronary artery disease [38]. In ex-vivo, SPARC expression was upregulated in both vascular endothelial cells and smooth muscle cells in atherosclerotic lesions
in rhesus macaques (Macaca mulatta) [39]. Together,these findings suggest that SPARC plays
a fundamental role in dyslipidemia and in the development of atherosclerosis.

Differentially expressed candidate miRNAs and their role in dyslipidemia
miR-545-3p. miR-545 is encoded in a long noncoding RNA associated with the X-linked
FTX gene (lnc-FTX). In our study, miR-545 had the greatest change in response to HCHF diet
challenge with a 322-fold change in high LDL-C baboons comparing the HCHF diet to the
baseline chow diet. This is the first study showing association of miR-545 expression with
LDL-C concentrations. Our miRNA/mRNA prediction analysis indicated that miR-545 gene-
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targets include LDLRAP1, LDLRAD4, and VLDLR. Elsewhere, in a study comparing patients
with CAD and controls, platelet-associated miR-545 was up-regulated in CAD patients compared to controls [40]. Future studies will validate the interaction of miR-545-3p with its genetargets and molecular mechanisms underlying dyslipidemia in a baboon model of
atherosclerosis.
miR-34. We found discordant expression of miR-34a� (miR-34a-3p), whereby the
miRNA is up-regulated in high LDL-C baboons but down-regulated in low LDL-C baboons.
However, very little is known about the role of miR-34a-3p in lipid metabolism. It is plausible
that miR-34a-3p plays an important role in lipid metabolism and atherosclerosis, especially
because it is evidently involved in both progenitor and EC apoptosis in vitro [41, 42]. The proapoptosis nature of miR-34a parallels the LDL-C mediated endothelial cell senescence and
may explain the up-regulation of miR-34a-3p in high LDL-C baboons. Hepatic miR- 34a was
up-regulated in mice fed a high-fat diet, which led to down-regulation of PPARα and SIRT1
[43]. An increasing body of evidence shows that miR-34a, which is a transcriptional target of
p53, has tumor suppressive properties mediating apoptosis, cell cycle arrest, and senescence by
inhibiting multiple oncogenic pathways [44, 45]. In some cancers, miR-34a is silenced typically
by hypermethylation of its regulatory promoter [46]. A miRNA mimic for miR-34 is currently
in clinical trial for patients with advanced solid tumors [44]. Further studies will investigate
whether the promoter that regulates mir-34a-3p transcription is differentially methylated
between low and high LDL-C baboons.
miR-221/222. miR-221/222 genes are located in close proximity on the X-chromosome
(Xp11.3) and are regulated in a coordinated manner [47]. In our study, we observed that both
miR-221 and miR-222 were down-regulated in high LDL-C baboons in response to HCHF
diet in concordance with our previous findings for the hepatic microRNAome for the same
animals [13].
Recent evidence suggests that both miR-221 and 222 are anti-apoptotic and silenced by
high LDL-C concentrations. Both miR-221 and miR-222 were down-regulated in oxidized
LDL-C-induced apoptotic EC in vitro [12], and exogenous inhibition of miR-221/221 led to
enhanced EC apoptosis by up-regulating Est1 and p21 [11]. A contrasting report showed that
miR-221/222 plays a pro-apoptotic role in EC in serum-deprived media [48]. Importantly,
serum-deprived media may not accurately represent the in vivo physiological condition. In
comparison, ox-LDL-C-induced EC morphological changes recapitulate similar events during
atherosclerosis in vivo [49]. This discrepancy may suggest that the functional role of a miRNA
depends on environmental context. Our data suggest that high LDL-C may influence the
down-egulation of expression of miR-221/222 in PBMCs, most likely to antagonize the
miRNA anti-apoptotic functional role, and to promote initialization of atherosclerosis, in concordance with findings in in-vitro experiments.
miR-148. miR-148 is a promising candidate that plays an important role in regulating
lipidemia [50, 51]. We observed a novel discordant expression of mature miR-148a/b-3p and
complementary ‘star’ sequences (miR-148a/b-5p) in low and high LDL-C baboons. miR-148a/
b-3p were up-regulated in low LDL-C while miR148a/b-5p were up-regulated in high LDL-C
baboons. This is the first study to report discordant expression of mature miR-148 and complementary sequences. These findings suggest that miR-148 and its complementary sequences
may play different roles in low and high LDL-C concentrations and are potential novel therapeutic targets for dyslipidemia and atherosclerosis.
Two recent studies have identified miR-148a as a negative regulator of LDLR expression
and activity [51, 52]. In mice, repression of miR-148a increased clearance of circulating labeled
LDL particles and decreased LDL-C levels [51]. In addition, miR-148a is a critical regulator of
HDL biogenesis and cholesterol efflux by targeting ABCA1, which plays an important role in

PLOS ONE | https://doi.org/10.1371/journal.pone.0213494 March 15, 2019

19 / 23

LDL-cholesterol and miRNA-gene networks

removal of excess cholesterol from peripheral cells, including macrophages in atherosclerotic
plaques [50]. Thus, miR-148a may play a unique role of decreasing LDL-C and increasing
HDL particles.
In conclusion, we have demonstrated molecular genetic differences in response to a HCHF
diet; these responses are evident in expression levels of individual genes and miRNAs, as well
as in expression of coordinated networks of genes and miRNAs. The miRNAs and miRNA
gene-targets differentially expressed in baboon with low LDL response versus high LDL
response to a HCHF diet are potential therapeutic targets for lowering LDL-C and alleviating
atherosclerosis burden. Although existing therapies are effective in lowering LDL-C concentrations and reducing the progression of atherosclerotic plaques in many people, the risk factors and incidence of CVD are still alarmingly high, and for some patients, the treatments are
either not effective or tolerable. The observed genetic differences may explain why current
therapies are not effective in some individuals. Thus, there is a need for a continued search for
novel therapies. Interestingly, miRNAs are being considered for treatment because of their
specificity and reduced side effects [44, 53]. Further studies are necessary to understand the
molecular mechanisms by which high LDL-C alters the expression of genes and miRNAs in
PBMCs, and whether there is a link between the expression profiles and the initiation of atherosclerosis. Such initiatives will enable delivery of a cassette of miRNA mimics or inhibitors
to facilitate fine-tuning of gene networks, rather than delivery of single candidate genes. While
miRNA therapeutics raise concerns over potential off-target effects current work on miR-122
has demonstrated that these therapies may prove more effective than, or complement, existing
treatment options for CVD. Because nonhuman primates and humans are phylogenetically
close, and are similar in their physiology and genetics, the baboon findings will be directly
translatable to humans.
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